Palatin prices $15.8M public offering; NYSE American listing resumes Nov 12

PALATIN TECHNOLOGIES INC

Priced upsized public offering of 2.43M shares at $6.50/unit; gross proceeds ~$15.8M.
Series J warrants ($6.50) expire 31 days after FDA accepts IND for obesity program; Series K ($8.125) expire 5 years but terminate early if J not exercised.
Underwriters granted 45-day option for additional 364,615 shares; closing expected Nov 12, 2025.
Proceeds to fund obesity program and working capital; potential additional $15.8M upon cash exercise of Series J warrants.
NYSE American listing resumes Nov 12 under PTN; compliance regained after reverse split and $8.8M revenue from Boehringer Ingelheim.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.